Molecular Responses to Small Regulating Molecules against Huanglongbing Disease

Publication Overview
TitleMolecular Responses to Small Regulating Molecules against Huanglongbing Disease
AuthorsMartinelli F, Dolan D, Fileccia V, Reagan RL, Phu M, Spann TM, McCollum TG, Dandekar AM
TypeJournal Article
Journal NamePloS one
Volume11
Issue7
Year2016
Page(s)e0159610
CitationMartinelli F, Dolan D, Fileccia V, Reagan RL, Phu M, Spann TM, McCollum TG, Dandekar AM. Molecular Responses to Small Regulating Molecules against Huanglongbing Disease. PloS one. 2016; 11(7):e0159610.

Abstract

Huanglongbing (HLB; citrus greening) is the most devastating disease of citrus worldwide. No cure is yet available for this disease and infected trees generally decline after several months. Disease management depends on early detection of symptoms and chemical control of insect vectors. In this work, different combinations of organic compounds were tested for the ability to modulate citrus molecular responses to HLB disease beneficially. Three small-molecule regulating compounds were tested: 1) L-arginine, 2) 6-benzyl-adenine combined with gibberellins, and 3) sucrose combined with atrazine. Each treatment contained K-phite mineral solution and was tested at two different concentrations. Two trials were conducted: one in the greenhouse and the other in the orchard. In the greenhouse study, responses of 42 key genes involved in sugar and starch metabolism, hormone-related pathways, biotic stress responses, and secondary metabolism in treated and untreated mature leaves were analyzed. TGA5 was significantly induced by arginine. Benzyladenine and gibberellins enhanced two important genes involved in biotic stress responses: WRKY54 and WRKY59. Sucrose combined with atrazine mainly upregulated key genes involved in carbohydrate metabolism such as sucrose-phosphate synthase, sucrose synthase, starch synthase, and α-amylase. Atrazine also affected expression of some key genes involved in systemic acquired resistance such as EDS1, TGA6, WRKY33, and MYC2. Several treatments upregulated HSP82, which might help protect protein folding and integrity. A subset of key genes was chosen as biomarkers for molecular responses to treatments under field conditions. GPT2 was downregulated by all small-molecule treatments. Arginine-induced genes involved in systemic acquired resistance included PR1, WRKY70, and EDS1. These molecular data encourage long-term application of treatments that combine these regulating molecules in field trials.

Features
This publication contains information about 1 features:
Feature NameUniquenameType
Fb0159Fb0159genetic_marker
Properties
Additional details for this publication include:
Property NameValue
Elocation10.1371/journal.pone.0159610
ISSN1932-6203
eISSN1932-6203
Publication ModelElectronic-eCollection
Publication Date2016
Journal AbbreviationPLoS ONE
DOI10.1371/journal.pone.0159610
LanguageEnglish
Language Abbreng
Publication TypeJournal Article
Journal CountryUnited States